SCHEMBL15057443

SCHEMBL15057443

CCN(CC)C(=O)C(F)(F)Oc1cc(F)c(N)cc1N

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MITF O75030 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HSD17B10 Q99714 3/20 0.33
▸ HSP90AA1 P07900 2/20 0.33
▸ HSP90AB1 P08238 2/20 0.33
▸ USP2 O75604 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ G6PD P11413 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ BLM P54132 1/20 0.32
▸ MLYCD O95822 1/20 0.32
▸ NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15057255 0.84 NOTUM (0.32) KDM4EALDH1A1HSD17B10HSP90AA1HSP90AB1
SCHEMBL15056545 0.75 MAPT (0.35) ALDH1A1HTTMEN1MAPTTHRB
SCHEMBL15059092 0.69 RIPK1 (0.40) USP2MEN1KMT2ANPC1RAB9A
SCHEMBL26000918 0.69 MAPT (0.34) KDM4EALDH1A1HTTHSD17B10USP2
SCHEMBL19299845 0.66 MLYCD (0.37) MEN1KMT2AMLYCD
SCHEMBL17101435 0.65 KDM4E (0.40) KDM4EALDH1A1HSD17B10USP2MEN1
SCHEMBL17875096 0.64 HDAC1 (0.36) ALDH1A1MAPTRAB9A
SCHEMBL11938191 0.63 MLYCD (0.35) MEN1KMT2AMLYCD
SCHEMBL9878081 0.63 HSP90AA1 (0.42) ALDH1A1HSP90AA1HSP90AB1MAPTL3MBTL1
SCHEMBL13832504 0.63 L3MBTL1 (0.52) ALDH1A1HTTHSD17B10MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9518045-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-12-13 — — US disclosed
US-9518045-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-12-13 — — US disclosed
US-9518045-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-12-13 — — US disclosed
EP-2885281-B1 CARBAMAT-BENZOXAZINONES USEFUL FOR PREPARING TRIAZIN-BENZOXAZINONES BASF SE (DE) 2016-12-07 — — EP disclosed
EP-2885296-B1 PROCESS FOR MANUFACTURING BENZOXAZINONES BASF SE (DE) 2016-06-29 — — EP disclosed
US-9359312-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-06-07 — — US disclosed
US-9359312-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-06-07 — — US disclosed
US-9359312-B2 Process for manufacturing benzoxazinones BASF SE (DE) 2016-06-07 — — US disclosed
US-9353070-B2 Carbamat-benzoxazinones BASF SE (DE) 2016-05-31 — — US disclosed
US-9353070-B2 Carbamat-benzoxazinones BASF SE (DE) 2016-05-31 — — US disclosed
US-20140316131-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES BASF SE (DE) 2014-10-23 — — US disclosed
US-20140316131-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES BASF SE (DE) 2014-10-23 — — US disclosed
WO-2014026928-A1 PROCESS FOR MANUFACTURING BENZOXAZINONES BASF SE (DE) 2014-02-20 — — WO disclosed
WO-2014026893-A1 CARBAMAT-BENZOXAZINONES BASF SE (DE) 2014-02-20 — — WO disclosed
WO-2013092856-A1 PROCESS FOR MANUFACTURING BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092856-A1 PROCESS FOR MANUFACTURING BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092859-A1 PROCESS FOR MANUFACTURING 4-SUBSTITUTED AMINO-BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092859-A1 PROCESS FOR MANUFACTURING 4-SUBSTITUTED AMINO-BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092858-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed
WO-2013092858-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES BASF SE (DE) 2013-06-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140316131-A1 PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES CYP2B6, UGT1A6, UGT2B17 KDM4E 797/4885ALDH1A1 465/4885MITF 1473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback